His primary areas of investigation include Gynecology, Mass screening, Internal medicine, Breast cancer and Mammography. His Gynecology research incorporates themes from Psychological intervention, Cancer, Observational study, Annual Screening and Overdiagnosis. His Internal medicine study frequently intersects with other fields, such as Oncology.
His Breast cancer research incorporates elements of Cancer screening and Obstetrics. His biological study spans a wide range of topics, including Mortality rate and Gerontology. His research integrates issues of Rate ratio and Prostate in his study of Prostate cancer.
His primary areas of study are Internal medicine, Breast cancer, Gynecology, Mass screening and Mammography. His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Stage. Breast cancer is a subfield of Cancer that Harry J. de Koning tackles.
His Mass screening research is multidisciplinary, incorporating elements of Overdiagnosis, Radiology and Annual Screening. His Prostate cancer research includes elements of Biopsy and Prostate. His work deals with themes such as Physical therapy, Clinical trial, Epidemiology and Lung cancer, Lung cancer screening, which intersect with Randomized controlled trial.
His primary scientific interests are in Internal medicine, Lung cancer, Lung cancer screening, Breast cancer and Incidence. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology. His Lung cancer research is multidisciplinary, incorporating perspectives in Psychological intervention, Cancer, Cancer screening, Economic evaluation and Lung.
His work on Breast cancer screening as part of general Breast cancer study is frequently linked to Statement, bridging the gap between disciplines. Harry J. de Koning has included themes like Observational study and Mass screening in his Breast cancer screening study. His research in the fields of Prostate-specific antigen and Prostate cancer screening overlaps with other disciplines such as Micro simulation.
Internal medicine, Incidence, Lung cancer, Breast cancer and Lung cancer screening are his primary areas of study. His Internal medicine study frequently draws connections between related disciplines such as Mortality reduction. His Incidence research integrates issues from Epidemiology, Colposcopy, Randomized controlled trial, Confidence interval and Overdiagnosis.
His work carried out in the field of Randomized controlled trial brings together such families of science as Affect, Rate ratio, Prostate-specific antigen, Prostate cancer and Screening Trial. His biological study spans a wide range of topics, including Cancer, Area under the curve, Nodule and Trial registration. His Breast cancer study combines topics in areas such as Nursing, Biopsy, Oncology and Mass screening.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2009)
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard.
The New England Journal of Medicine (2004)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2012)
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W. van der Cruijsen.
Journal of the National Cancer Institute (2003)
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Harry J. de Koning;Carlijn M. van der Aalst;Pim A. de Jong;Ernst T. Scholten.
The New England Journal of Medicine (2020)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma;Ruth Etzioni;Alex Tsodikov;Angela Mariotto.
Journal of the National Cancer Institute (2009)
Management of lung nodules detected by volume CT scanning
Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten.
The New England Journal of Medicine (2009)
Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms
Jeanne S. Mandelblatt;Kathleen A. Cronin;Stephanie Bailey;Donald A. Berry.
Annals of Internal Medicine (2009)
Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force
Harry J. de Koning;Rafael Meza;Sylvia K. Plevritis;Kevin ten Haaf.
Annals of Internal Medicine (2014)
Quality-of-life effects of prostate-specific antigen screening.
Eveline A M Heijnsdijk;Elisabeth M Wever;Anssi Auvinen;Jonas Hugosson.
The New England Journal of Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Groningen
Erasmus MC
Utrecht University
University Medical Center Groningen
Utrecht University
University of Amsterdam
Georgetown University
Radboud University Nijmegen
Erasmus MC
Radboud University Nijmegen
Griffith University
California Institute of Technology
University of California, Santa Barbara
Tel Aviv University
University of Salerno
Universidade de São Paulo
University of Cologne
Los Alamos National Laboratory
Australian National University
Stockholm University
Fudan University
Karolinska Institute
University of New South Wales
Victoria University of Wellington
University of Kentucky
University of Utah